The symposium will cover all aspects of the chemistry associated with development of diagnosis and therapeutic studies of human cancer together with the clinicians.
The spectroscopic analytical technology has been an important part in the new medical field, for example, photodynamic diagnosis (PD) and photodynamic therapy (PDT) with laser in the visible light region.
Recently, medical imaging analysis has greatly progressed and widened on the basis of magnetic resonance spectroscopic technologies, X-rays (neutron, heavy particle beams and higher energy X-rays), visible, infrared regions, and micro waves and ultrasounds for emerging more specific and reliable cancer diagnostic images.
We shall have 5 different sessions: (1) PD, PDT and combination therapy with PDT in clinical and animal model of cancer, (2) Infrared spectroscopic micro-imaging of cancer tissues or cells, (3) Magnetic resonance imaging including electron spin resonance (ESR) spectroscopic imaging in cancer, (4) X-ray and heavy atom sensitizing therapy of cancer tissues and cells. (5) Poster presentations for (1) – (4) sessions.
We are hopeful that spectroscopic analysis and imaging technologies will provide useful biomarkers in the diagnoses and planning treatment in human cancers.